88 results
Page 2 of 5
424B5
znv3yhn
24 Apr 23
Prospectus supplement for primary offering
4:53pm
8-K
EX-99.1
mfzgpys1ak
8 Nov 22
IDEAYA Biosciences, Inc. Reports Third Quarter 2022
6:02am
424B5
u9gq 0mo10hvm8ae7fr
15 Sep 22
Prospectus supplement for primary offering
5:03pm
424B5
5rakli
14 Sep 22
Prospectus supplement for primary offering
5:01pm
8-K
EX-99.1
2cyfnvqrt0g6wj
15 Aug 22
IDEAYA Biosciences, Inc. Reports Second Quarter 2022
6:25am
8-K
EX-99.1
9eoo8 7a9
27 Jul 22
IDEAYA Announces Clinical Trial Collaboration with Amgen to Evaluate MAT2A-PRMT5 Synthetic Lethality Combination in MTAP Deleted Tumors
6:13am
8-K
EX-99.1
k720uzrk761htj
10 May 22
IDEAYA Biosciences, Inc. Reports First Quarter 2022
6:03am
8-K
EX-99.1
op65r2 1smewv8
6 Apr 22
IDEAYA Biosciences Appoints Catherine Mackey, Ph.D., to its Board of Directors
6:03am
8-K
EX-99.1
xo0mlbo8b1c3iqx
15 Mar 22
IDEAYA Biosciences, Inc. Reports 2021 Financial Results
6:03am
8-K
EX-99.1
ynd7 0hqyv
15 Nov 21
IDEAYA Biosciences, Inc. Reports Third Quarter 2021
6:04am
8-K
EX-99.1
qevueyxf iayguwj
10 Aug 21
IDEAYA Biosciences, Inc. Reports Second Quarter 2021
6:04am
424B5
vzigfs
8 Jul 21
Prospectus supplement for primary offering
4:02pm
424B5
zg9 9yssujj4
6 Jul 21
Prospectus supplement for primary offering
4:04pm